OVID
OVID
NASDAQ · Biotechnology

Ovid Therapeutics Inc

$2.78
+0.10 (+3.73%)
As of Jul 4, 2:10 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,376.3% upside
Low Target $30.97
Average Target $41.04
High Target $66.83
Current Price $2.78
Current
$2.78
Target
$41.04
$30.97 $41.04 avg $66.83
Scenario Analysis
Bear Case
$30.97
1,014.0%
Low target
Base Case
$41.04
+1,376.3%
Avg target
Bull Case
$66.83
+2,304.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.11
-10.5% from high
52-Week Low
$0.32
+773.4% from low
Target vs 52W High
$41.04
+1,221.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 -1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -49.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +176.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -88.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -67.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.8%